--- title: "Chinese fintech products provider Zenta Group prices US IPO at $4, the low end of the range" type: "News" locale: "en" url: "https://longbridge.com/en/news/256603558.md" description: "Zenta Group, a Chinese fintech products provider, has priced its US IPO at $4 per share, raising $6 million by offering 1.5 million shares. This pricing is at the low end of the expected range of $4 to $5. With a market cap below $50 million, Zenta will not be included in Renaissance Capital's 2025 IPO statistics. The company, which has shifted focus to fintech in 2023, plans to list on Nasdaq under the symbol ZGM, with Cathay Securities as the sole bookrunner." datetime: "2025-09-09T16:04:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/256603558.md) - [en](https://longbridge.com/en/news/256603558.md) - [zh-HK](https://longbridge.com/zh-HK/news/256603558.md) --- # Chinese fintech products provider Zenta Group prices US IPO at $4, the low end of the range Zenta Group, which offers a credit risk analysis platform and distributes fintech products in China, raised $6 million by offering 1.5 million shares at $4, the low end of the range of $4 to $5. **_Because the company has a market cap of less than $50 million at pricing, Zenta Group will be excluded from Renaissance Capital's 2025 IPO stats._** Zenta Group is a professional services provider in Macau. Originally focused on providing industrial park and business investment consultation services, the company started developing its fintech business in the 2H23, which accounted for a majority of its revenue in the FY24. Its fintech business currently involves selling a platform for analyzing customer credit risk and consumption behaviors, as well as acting as an intermediary distributor of fintech products offered by its supplier Guo Yan. Zenta Group plans to list on the Nasdaq under the symbol ZGM. Cathay Securities acted as sole bookrunner on the deal. ### Related Stocks - [ZGM.US](https://longbridge.com/en/quote/ZGM.US.md) - [ZTG.US](https://longbridge.com/en/quote/ZTG.US.md)